Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM

Table 1

Comparison of the demographic characteristics and baseline glycemic parameters between the groups.

Characteristics	Group 1; Insulin + Ros; (n = 30)	Group 2; Insulin alone; (n = 31)
Sex (women/men)	18/12	17/14	0.570
Age (years)	27.55 ± 8.48	27.09 ± 5.38	0.734
Diabetes duration (years)	10 ± 4.95	9.6 ± 4.92	0.814
BW (kg)	66.59 ± 8.6	63.13 ± 8.2	0.768
BMI (kg/m^2)	24.17 ± 2.62	22.97 ± 2.74	0.606
WC (cm)	83.80 ± 8.26	78.71 ± 9.11	0.135
WHR	0.85 ± 0.06	0.80 ± 0.06	0.773
FPG (mg/dL)	249.1 ± 69.5	223.2 ± 78.5	0.167
HbA1c (%)	9.22 ± 1.77	8.75 ± 1.14	0.886
eGDR (mg/kg/min)	8.53 ± 2.70	9.25 ± 3.18	0.120

BW: body weight; BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; HbA1c: glycosylated hemoglobin; eGDR: estimated glucose disposal rate.